Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.
PsyArXiv May 14, 2026 Jacob Cohen, Peter Parbo, Per Trads Ørskov et al. preprint
A double-blind randomized controlled trial will test whether low doses of psilocybin, given alongside virtual reality exposure therapy, can reduce symptoms of social anxiety disorder. The protocol describes the planned methods but does not yet report results.